Prothena (NASDAQ:PRTA) Price Target Raised to $62.00
Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Several other equities analysts have also recently issued reports on the stock. Chardan Capital started coverage on shares of Prothena in […]
Prothena (NASDAQ:PRTA – Free Report) had its price target boosted by Oppenheimer from $58.00 to $62.00 in a report published on Friday,Benzinga reports. They currently have an outperform rating on the biotechnology company’s stock. Several other equities analysts have also recently issued reports on the stock. Chardan Capital started coverage on shares of Prothena in […]
